Transmyocardial laser revascularization versus medical therapy for refractory angina

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Briones, Eduardo ^a   Lacalle, Juan Ramon ^b   Marin Leon, Ignacio ^c   Rueda, José Ramón ^d  

^a CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ANGINA PECTORIS; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE SEVERITY; EXERCISE TOLERANCE; HEART EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; KINESIOTHERAPY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SYSTEMATIC REVIEW; THORACOTOMY; TREADMILL EXERCISE; TREATMENT DURATION; ADVERSE EFFECTS; LOW LEVEL LASER THERAPY; META ANALYSIS; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANGINA PECTORIS; HUMANS; LASER THERAPY; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THORACOTOMY;

EID: 84934343356     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003712.pub3     Document Type: Review

References (84)

1. Aaberge L, Askhus S, Nordstrand K, Abdelnoor M, Ihlen H, Forfang K. Myocardial performance after transmyocardial revascularization with CO(2) laser. A dobutamine stress echocardiographic study. European Journal of Echocardiography 2001;2(3):187-96.
2. Aaberge L, Nordstrand K, Dragsund M, Saatvedt K, Endresen K, Golf S, et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian Randomized Trial. Journal of the American College of Cardiology 2000;35:1170-7.
3. Aaberge L, Rootwelt K, Blomhoff S, Saatvedt K, Abdelnoor M, Forfang K. Continued symptomatic improvement three to five years after transmyocardial laser revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial laser revascularization. Journal of the American College of Cardiology 2002;39:1588-93.
4. Aaberge L, Rootwelt K, Smith HJ, Nordstrand K, Forfang K. Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods. Scandinavian Cardiovascular Journal 2001;35:8-13.
5. Allen KB, Dowling RD, Angell WW, Gangahar DM, Fudge TL, Richenbacher W, et al. Transmyocardial laser revascularization: 5 years follow-up of a prospective, randomized trial. Annals of Thoracic Surgery 2004;77:1228-34.
6. Allen KB, Dowling RD, Fudge TL, Schoettle P, Sleinger SL, Gangahar DM, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. The New England Journal of Medicine 1999;341:1029-36.
7. Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, et al. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet 1999;354:885-90.
8. Frazier OH, March RJ, Horvath KA, Transmyocardial Carbon Dioxide Laser Revascularization Group. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. New England Journal of Medicine 1999;341:1021-8.
9. Hovarth KA, Aranki SF, Cohn LH, March RJ, Frazier OH, Kadipasaoglu KA, et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser. Circulation 2001;104(12 Suppl 1):I81-4.
10. March RJ. Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial. Seminars in Thoracic and Cardiovascular Surgery 1999;11(1):12-8.
11. Spertus JA, Jones PG, Coen M, Garg M, Bliven B, O'Keefe J, et al. Transmyocardial CO2 laser revascularization improves symptoms, function and quality of life: 12-month results from a randomized controlled trial. American Journal of Medicine 2001;111:341-8.
12. Jones JW, Schmidt SE, Richman BW, Miller CC, Sapire KJ, Burkhoff D, et al. Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status. Annals of Thoracic Surgery 1999;67:1596-1602.
13. Burns SM, Brown S, White CA, Tait S, Sharples L, Schofield PM. Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization. American Journal of Cardiology 2001;87(7):861-7. [CENTRAL: CN-00372857]
14. Caine N, Tait S, Campbell H, Buxton M, Sharples LD, Schofield PM, et al. The UK trial of transmyocardial laser revascularisation (TMLR): cost effectiveness. 15th Annual Meeting of the International Society of Technology Assessment in Health Care; 1999 Jun 20-23. 1999:122.
15. Campbell HE, Tait S, Buxton MJ, Sharples LD, Caine N, Schofield PM, et al. A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris. European Journal of Cardio-Thoracic Surgery 2001;20:312-8.
16. Campbell HE, Tait S, Sharples LD, Caine N, Gray TJ, Schofield PM, et al. Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris. European Journal of Health Economics 2005;6(4):288-97. [CENTRAL: CN-00552367]
17. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow, T, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 1999;353:519-24.
18. Tait S, Caine N, Batas D, Sharples LD, Buxton M, Burns S, et al. The UK trial of transmyocardial laser revascularisation (TMLR): health related quality of life (HRQOL) [abstract]. 15th Annual Meeting of the International Society of Technology Assessment in Health Care; 1999 Jun 20-23. 1999:62. [CENTRAL: CN-00476490]
19. Huikeshoven M, van der Sloot JAP, Tukkie R, van Gemert MJC, Tijssen JGP, Beek JF. Improved quality of life after XeCl excimer transmyocardial laser revascularization: results of a randomized trial. Lasers in Surgery and Medicine 2003;33:1-7. [DOI: 10.1002/lsm.10189]
20. van der Sloot JAP, Huikeshoven M, Tukkie R, Verbene HJ, van der Meulen J, van Eck-Smit BLF, et al. Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial. Annals of Thoracic Surgery 2004;78(3):875-81.
21. Allen KB, Dowling RD, DelRossi AJ, Realyvasques F, Lefrak EA, Pfeffer TA, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. Journal of Thoracic and Cardiovascular Surgery 2000;119(3):540-9. [CENTRAL: CN-00275669]
22. Appelman YE, Piek JJ, Strikwerda S, Tijssen JG, de Feyter PJ, David GK, et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet 1996;347(8994):79-84. [CENTRAL: CN-00122402]
23. Appelman YE, Piek JJ, Redekop WK, de Feyter PJ, Koolen JJ, David GK, et al. Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial. Heart (British Cardiac Society) 1998;79(1):34-8. [CENTRAL: CN-00148577]
24. Appelman YE, Piek JJ, van der Wall EE, Redekop WK, van Royen EA, Fioretti PM, et al. Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions. International Journal of Cardiac Imaging 2000;16(4):267-77. [CENTRAL: CN-00327681]
25. Dixon SR, Schreiber TL, Rabah M, Lee DT, Kelco KL, O'Neill WW. Immediate effect of percutaneous myocardial laser revascularization on hemodynamics and left ventricular systolic function in severe angina pectoris. American Journal of Cardiology 2001;87(5):516-9. [CENTRAL: CN-00328342]
26. Dowling R, Thielmeier K, Ghaly A, Barber D, Boice T, Dine A. Improved pain control after cardiac surgery: results of a randomized, double-blind, clinical trial. Journal of Thoracic and Cardiovascular Surgery 2003;126(5):1271-8. [CENTRAL: CN-00459447]
27. Dziuk M, el-Deeb H, Britton KE, Edmondson SJ, Piechota W, Cholewa M. Clinical outcome of patients after transmyocardial laser revascularization alone and combined with coronary artery bypass grafting [Kliniczna ocena efektu przezsercowej rewaskularyzacji laserowej polaczonej lub niepolaczonej z pomostowaniem aortalno-wiencowym]. Polski Merkuriusz Lekarski 2003;15(90):534-6. [CENTRAL: CN-00559730]
28. Frazier OH, Tuzun E, Eichstadt H, Boyce SW, Lansing AM, March RJ, et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Texas Heart Institute Journal 2004;31(3):231-9. [CENTRAL: CN-00492808]
29. Guleserian KJ, Maniar HS, Camillo CJ, Bailey MS, Damiano RJ, Moon MR. Quality of life and survival after transmyocardial laser revascularization with the holmium: YAG laser. Annals of Thoracic Surgery 2003;75(6):1842-7; discussion 1847-8. [CENTRAL: CN-00558872]
30. Horvath KA. Results of clinical trials of transmyocardial laser revascularization versus medical management for end-stage coronary disease. Journal of Clinical Laser Medicine and Surgery 2000;18(5):247-52.
31. Horvath KA. Transmyocardial laser revascularization in the treatment of myocardial ischemia. Journal of Cardiac Surgery 2000;15(4):271-7.
32. Horvath KA. Results of prospective randomized controlled trials of transmyocardial laser revascularization. Heart Surgery Forum 2002;5(1):33-9.
33. Horvath KA. Transmyocardial laser revascularization. Journal of Cardiac Surgery 2008;23(3):266-76.
34. Kniazeva TA, Nagapet'ian VK. The use of infrared laser radiation in the rehabilitation of IHD patients after the surgical revascularization of the myocardium [Ispol'zovanie infrakrasnogo lazernogo izlucheniia v reabilitatsii bol'nykh IBS posle khirurgicheskoi revaskuliarizatsii miokarda]. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury 1994;Nov-Dec(6):10-2. [CENTRAL: CN-00114479]
35. Leon MB, Kornowski R, Downey WE, Weisz G, Baim DS, Bonow RO, et al. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. Journal of the American College of Cardiology 2005;46(10):1812-9. [CENTRAL: CN-00531924]
36. Loubani M, Chin D, Leverment JN, Galiñanes M. Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass. Annals of Thoracic Surgery 2003;76(4):1163-6. [CENTRAL: CN-00458111]
37. McNab D, Khan SN, Sharples LD, Ryan JY, Freeman C, Caine N, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. European Heart Journal 2006;27(9):1048-53. [CENTRAL: CN-00563544]
38. Milano, Carlo AD. Transmyocardial revascularization with a holmium laser: preliminary results [Rivascolarizzazione transmiocardica con laser ad olmio: risultati preliminari]. Giornale Italiano Di Cardiologia 1997;27(10):1011-8. [CENTRAL: CN-00338266]
39. Myers J, Oesterle SN, Jones J, Burkhoff D. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. American Heart Journal 2002;143(6):1052-7.
40. Oesterle SN. Laser percutaneous myocardial revascularization. American Journal of Cardiology 1999;83(4 A):46B-52B. [CENTRAL: CN-00413614]
41. Oesterle SN, Sanborn TA, Ali N, Resar J, Ramee SR, Heuser R, et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 2000;356(9243):1705-10. [CENTRAL: CN-00331210]
42. Salem M, Rotevatn S, Stavnes S, Brekke M, Vollset SE, Nordrehaug JE. Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris. American Journal of Cardiology 2004;93(9):1086-91. [CENTRAL: CN-00469504]
43. Salem M, Rotevatn S, Stavnes S, Brekke M, Pettersen R, Kuiper K, et al. Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures. International Journal of Cardiology 2005;104(2):144-51. [CENTRAL: CN-00552248]
44. Salem M, Rotevatn S, Nordrehaug JE. Long-term results following percutaneous myocardial laser therapy. Coronary artery disease 2006;17(4):385-90. [CENTRAL: CN-00565446]
45. Stone GW, Teirstein PS, Rubenstein R, Schmidt D, Whitlow PL, Kosinski EJ, et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecognizable chronic total occlusions. Journal of the American College of Cardiology 2002;39(10):1581-7. [CENTRAL: CN-00380195]
46. Vasil'ev AP, Strel'tsova NN, Senatorov IuN. Efficacy of laser therapy in patients with ischemic heart disease [Effektivnost' lazeroterapii bol'nykh ishemicheskoi bolezn'iu serdtsa]. Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury 2003;Jul-Aug(4):10-3. [CENTRAL: CN-00457587]
47. Yang SS, Li WM, Yin LL, Li Y, Fan Y, Han W, et al. Chronic effects of percutaneous transmyocardial laser revascularization in patients with refractory angina. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35(1):51-4.
48. Bienenfeld L, Frishman W, Glasser SP. The placebo effect in cardiovascular disease. American Heart Journal 1996;132(6):1207-21.
49. Borrás X, Garcia-Moll X, Gomez-Doblas JJ, Zapata A, Artigas R, AVANCE study researchers. Stable angina in Spain and its impact on quality of life. The AVANCE registry. Revista Espanol de Cardiologia (English Edition) 2012;65(8):734-41.
50. Briones E, Rodriguez FJ. Eficacia, seguridad y eficiencia de la revascularización transmiocárdica con láser [Efficacy, security and efficiency of transmyocardial laser revascularization]. Madrid: Ministerio de Sanidad y Consumo, 2003. [: ISBN 84-760-664-2]
51. Burkhoff D, Jones JW, Becker LC. Variability of myocardial perfusion defects by thallium 201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery. Journal of the American College of Cardiology 2001;38:1033-9.
52. Caine N, Schofield PM, Wallwork J, Sharples LD. British trial of transmyocardial revascularisation is continuing. BMJ 1998;316(7129):474-5. [CENTRAL: CN-00258677]
53. Campbell F, Messina J, FitzGerald P, Cantrell A, Czoski-Murray C. Systematic review of the efficacy and safety of transmyocardial and percutaneous laser revascularisation for refractory angina pectoris. Review body for interventional procedures (ScHARR). Shefield 2008.
54. Clifford DM, Fisher SA, Brunskill SJ, DoreeC, MathurA, Watt S, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD006536.pub3]
55. Cooley DA, Frazier OH, Kadipasaoglu KA, Lindenmeir MH, Pehlivanoglu S, Kolff JW, et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. Journal of Thoracic and Cardiovascular Surgery 1996;111:791-7.
56. Downing SW. Transmyocardial laser revascularization. New England Journal of Medicine 2000;342:436-8.
57. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology 2012;60(24):e44-e164.
58. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir MH, Barasch E, et al. Myocardial revascularization with laser: preliminary findings. Circulation 1995;92(Suppl II):58-65.
59. Higgins JPT, Altman DG, Sterne AC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
60. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization: operative techniques and clinical results at two years. Journal of Thoracic and Cardiovascular Surgery 1996;111:1047-53.
61. Jolicoeur EM. Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification. Canadian Journal of Cardiology 2012;28:S50-S59.
62. Kim MC, Kini A, Sharma SK. Refractory angina pectoris. Journal of the American College of Cardiology 2002;39:923-34.
63. Lange RA, Hillis LD. Transmyocardial laser revascularization. New England Journal of Medicine 1999;341:1075-6.
64. Liao L, Sarria-Santamera A, Matchar DB, Huntington AH, Lin S, Whellan DJ, et al. Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization. American Journal of Cardiology 2005;95:1243-5. [DOI: 10.1016/j.amjcard.2005.01.057]
65. Macklin R. The ethical problems with sham surgery in clinical research. New England Journal of Medicine 1999;341(13):992-6. [MEDLINE: 10498498]
66. Manchanda A, Aggarwal A, Aggarwal N, Soran O. Management of refractory angina pectoris. Cardiology Journal 2011;18(4):343-51.
67. McGillion M, Arthur HM, Cook A, Carroll SL, Victor JC, L'allier PL, et al. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Canadian Journal of Cardiology 2012;28(2 Suppl):S20-41.
68. Mirhoseini M, Muckerheide M, Cayton MM. Transventricular revascularization by laser. Lasers in Surgery and Medicine 1982;2:187-98.
69. Mirhoseini M, Shelgikar S, Cayton MM. Transmyocardial laser revascularization: a review. Journal of Clinical Laser Medicine and Surgery 1993;11:15-9.
70. Medicare Service Advisory Committee. Transmyocardial laser revascularization. Canberra: Commonwealth of Australia, 1999.
71. Nägele H, Stubbe HM, Nienaber C, Rodiger W. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up. European Heart Journal 1998;19(10):1525-30.
72. Peduzzi P, Detre K, Wittes J, Holford T. Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery study. Journal of Thoracic and Cardiovascular Surgery 1991;101:481-7.
73. Peterson ED, Kaul P, Kaczmarek RG, Hammill BG, Armstrong PW, Bridges CR, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. Journal of the American College of Cardiology 2003;42(9):1611-6.
74. Prêtre R, Turina MI. Laser to the heart: magic but costly, or only costly?. Lancet 1999;353:512-3.
75. Qaseem A, Fihn SD, Dallas P, Williams S, Owens DK, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Annals of Internal Medicine 2012;157(10):735-43.
76. Saririan M, Eisenberg MJ. Myocardial laser revascularization for the treatment of end-stage coronary artery disease. Journal of the American College of Cardiology 2003;41(2):173-83.
77. Schofield PM, McNab D. NICE evaluation of transmyocardial laser revascularisation for refractory angina revascularisation and percutaneous laser. Heart 2010;96:312-3.
78. Sharples L, Schofield P, Caine N, Wallwork J. Transmyocardial laser revascularisation in clinical practice. Lancet 1999;354:1994-5.
79. Smith JA, Dunning JJ, Parry AJ, Large SR, Wallwork J. Transmyocardial laser revascularization. Journal of Cardiac Surgery 1995;10(5):569-72. [CENTRAL: CN-00120891]
80. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
81. Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA 2010;303(18):1841-7.
82. Williams SG, Wright DJ, Lindsay SJ, Tan LB. Transmyocardial laser revascularisation in clinical practice. Lancet 1999;354:1994-5.
83. Williams SG, Wright DJ, Tan LB. Transmyocardial laser revascularization. New England Journal of Medicine 2000;342:436-8.
84. Briones E, Lacalle JR, Marin I. Transmyocardial laser revascularization versus medical therapy for refractory angina. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003712.pub2]